National Healthcare Properties Valuation
Is 4ON undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 4ON when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 4ON's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 4ON's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4ON?
Key metric: As 4ON is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 4ON's PS Ratio? | |
|---|---|
| PS Ratio | 0.1x |
| Sales | US$352.84m |
| Market Cap | US$52.72m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.4x |
| Enterprise Value/EBITDA | -49.2x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 4ON's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.5x | ||
FVI Fair Value REIT-AG | 2.3x | n/a | €54.7m |
DKG Deutsche Konsum REIT-AG | 1.3x | -12.7% | €140.6m |
SCWEL Wellder Senior Assets SOCIMI | 41.2x | n/a | €93.0m |
HABA Hamborner REIT | 5x | 1.7% | €527.9m |
4ON National Healthcare Properties | 0.1x | n/a | €52.7m |
Price-To-Sales vs Peers: 4ON is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (12.5x).
Price to Sales Ratio vs Industry
How does 4ON's PS Ratio compare vs other companies in the Global Health Care REITs Industry?
Price-To-Sales vs Industry: 4ON is good value based on its Price-To-Sales Ratio (0.1x) compared to the Global Health Care REITs industry average (6.7x).
Price to Sales Ratio vs Fair Ratio
What is 4ON's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.1x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 4ON's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Argan
€1.7b
Engages in designing, building, developing, owning, leasing, and managing logistical platforms in France.
871
€63.70
7D
-3.0%
1Y
-16.2%
Allied Properties Real Estate Investment Trust
CA$2.5b
Allied is a leading owner-operator of distinctive urban workspace in Canada's major cities.
5G8
CA$12.17
7D
-0.5%
1Y
1.6%
NSI
€376.7m
A specialist commercial property investor and the only listed real estate investment trust (REIT) focused on well-located offices in economic growth regions in The Netherlands.
N4RN
€19.46
7D
0%
1Y
12.4%